Product
Help
Pricing
About
Jobs
Log in
Get started
Concept
Add to collection
Alfacalcidol
OpenAlex ID:
C2779126354
Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis population
2003
·
T. Shoji
, K. Shinohara
, et al.
·
Nephrology Dialysis Transplantation
·
380
Therapeutic management of hypophosphatemic rickets from infancy to adulthood
2014
·
Agnès Linglart
, Martin Biosse-Duplan
, et al.
·
Endocrine Connections
·
372
Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure
1995
·
Neveen A T Hamdy
, John A Kanis
, et al.
·
BMJ
·
341
Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis
2006
·
Ron N.J. de Nijs
, Johannes W.G. Jacobs
, et al.
·
New England Journal of Medicine
·
235
PDF
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures — A randomized, active comparator, double-blind study
2011
·
Toshio Matsumoto
, Masako Ito
, et al.
·
Bone
·
201
PDF
Alfacalcidol Reduces the Number of Fallers in a Community‐Dwelling Elderly Population with a Minimum Calcium Intake of More Than 500 Mg Daily
2004
·
Laurent Dukas
, Heike A. Bischoff
, et al.
·
Journal of the American Geriatrics Society
·
191
Primary hyperparathyroidism and the skeleton
2008
·
Leif Mosekilde
·
Clinical Endocrinology
·
181
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
2005
·
J. D. Ringe
, H. Faber
, et al.
·
Rheumatology International
·
181
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity
2008
·
Alex J. Brown
, Eduardo Slatopolsky
·
Molecular Aspects of Medicine
·
178
Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study
2003
·
J. D. Ringe
, A. Dorst
, et al.
·
Osteoporosis International
·
176
Vitamin D endocrine system and osteoclasts
2014
·
Naoyuki Takahashi
, Naoyuki Udagawa
, et al.
·
BoneKEy Reports
·
162
PDF
Alfacalcidol Inhibits Bone Resorption and Stimulates Formation in an Ovariectomized Rat Model of Osteoporosis: Distinct Actions from Estrogen
2000
·
Ayako Shiraishi
, Satoshi Takeda
, et al.
·
Journal of Bone and Mineral Research
·
160
Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial: Clinical article
2011
·
Ken Nagahama
, Masahiro Kanayama
, et al.
·
Journal of Neurosurgery Spine
·
153
Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis
2005
·
F. Richy
, E. Schacht
, et al.
·
Calcified Tissue International
·
144
A Vitamin D Analog Ameliorates Glomerular Injury on Rat Glomerulonephritis
2001
·
Kojiro Makibayashi
, Mitsuyoshi Tatematsu
, et al.
·
American Journal Of Pathology
·
144
PDF
Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study
2001
·
J. D. Ringe
, H. Faber
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
137
A Double-Masked Multicenter Comparative Study Between Alendronate and Alfacalcidol in Japanese Patients with Osteoporosis
1999
·
M. Shiraki
, K. Kushida
, et al.
·
Osteoporosis International
·
134
Prediction of Permanent Hypoparathyroidism after Total Thyroidectomy
2014
·
M. Almquist
, P. Hallgrimsson
, et al.
·
World Journal of Surgery
·
132
Prophylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis
1999
·
J. Y. Reginster
, D. Kuntz
, et al.
·
Osteoporosis International
·
132
ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis
2002
·
Y Uchiyama
, Y HiguchI
, et al.
·
Bone
·
126
Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation
2004
·
Armando Torres
, Sagrario García
, et al.
·
Kidney International
·
124
PDF
Impact of Vitamin D on Infectious Disease
2014
·
Malcolm D. Kearns
, Jessica A. Alvarez
, et al.
·
The American Journal of the Medical Sciences
·
121
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-Hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison
2001
·
Hla M. Maung
, Loganathan Elangovan
, et al.
·
American Journal of Kidney Diseases
·
121
Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study
2004
·
J. D. Ringe
, A. Dorst
, et al.
·
Rheumatology International
·
118
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study
2008
·
Johann D. Ringe
, Parvis Farahmand
, et al.
·
Rheumatology International
·
114
Show more works
View as search
Works count:
1,320
Citation count:
16,920
Year
Topic
Type